factually
Index/Topics/Alzheimer's Disease Treatment Trials 2026

Alzheimer's Disease Treatment Trials 2026

Alzheimer's disease treatment trials expected to report results in 2026, including Eli Lilly's remternetug, AR1001, buntanetap, metformin, BIIB080, and aducanumab confirmatory ENVISION study

Fact-Checks

1 result
Jan 15, 2026
Most Viewed

Which Phase III Alzheimer's drug trials are expected to report results in 2026 and what mechanisms do they target?

The Alzheimer’s field is poised for multiple high‑profile Phase III and confirmatory readouts in 2026, with programs ranging from next‑generation anti‑amyloid antibodies to oral small molecules and me...